International Stem Cell CORP (ISCO) › Operating IncomeInternational Stem Cell CORP (ISCO) — Operating IncomeAnnual figures by period end, from SEC filings.2010-12-31: -$10.46M2011-12-31: -$11.36M2012-12-31: -$9.81M2013-12-31: -$7.55M2014-12-31: -$8.68M2015-12-31: -$4.56M2016-12-31: -$4.85M2017-12-31: -$4.94M2018-12-31: -$3.47M2019-12-31: -$5.73M2020-12-31: -$2.82M2021-12-31: -$1.92M2022-12-31: -$183.0K2023-12-31: -$663.0K2024-12-31: -$68.0K2025-12-31: -$267.0K-$267.0K2010-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31-$267.0K—2026-03-30From 2025-01-012024-12-31-$68.0K—2026-03-30From 2024-01-012023-12-31-$663.0K—2025-03-28From 2023-01-012022-12-31-$183.0K—2024-03-28From 2022-01-012021-12-31-$1.92M—2023-03-30From 2021-01-012020-12-31-$2.82M—2022-03-29From 2020-01-012019-12-31-$5.73M—2021-03-30From 2019-01-012018-12-31-$3.47M—2020-06-01From 2018-01-012017-12-31-$4.94M—2019-04-15From 2017-01-012016-12-31-$4.85M—2018-04-09From 2016-01-012015-12-31-$4.56M—2017-03-31From 2015-01-012014-12-31-$8.68M—2016-03-30From 2014-01-012013-12-31-$7.55M—2015-03-30From 2013-01-012012-12-31-$9.81M—2014-03-17From 2012-01-012011-12-31-$11.36M—2013-03-26From 2011-01-012010-12-31-$10.46M—2012-03-16From 2010-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)